Marathon Pharmaceuticals Announces Submission of Deflazacort New Drug Application to the FDA Biotech Investing
Great Basin Granted Expanded Patent for Its Highly Sensitive AMPED Molecular Detection Technology Biotech Investing
Aerpio Therapeutics Reports Peer-Reviewed Publication of Positive Clinical Results from the Phase 2a Study of Lead Candidate, AKB-9778, in Diabetic Macular Edema (DME): The TIME-2 Trial Biotech Investing
Alpine Immune Sciences Announces $48 Million Series A Financing to Support Discovery and Development of the Next Generation of Immunotherapies Biotech Investing
Biotie Therapies Corp. Announces That the Delisting of Its American Depositary Shares from NASDAQ Global Select Market Has Become Effective Biotech Investing
Aimmune Therapeutics Announces Phase 2 Extended Maintenance Data Supporting Safety and Tolerability Profile of AR101 for Peanut Allergy Biotech Investing
Acceleron and Celgene Announce Updated Results from an Ongoing Phase 2 Study of Luspatercept in Beta-Thalassemia Presented at the 21st Congress of the European Hematology Association Biotech Investing
Concert Pharmaceuticals Presents CTP-656 Phase 1 Results at European Cystic Fibrosis Conference Biotech Investing
Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp. Biotech Investing
